Full-Time

AI Product Engineer

Agents

Confirmed live in the last 24 hours

V7 Labs

V7 Labs

51-200 employees

Automated image annotation and AI training

Enterprise Software
AI & Machine Learning
Healthcare

Mid

Company Does Not Provide H1B Sponsorship

London, UK

Hybrid working with flexibility; central London office near Oxford Circus.

Category
Full-Stack Engineering
Software Engineering
Required Skills
LLM

You match the following V7 Labs's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Strong interest in and commitment to staying abreast of the rapidly evolving Foundation Model eco-system, and a drive to leverage these capabilities in novel, real world use cases.
  • Experience delivering Large Language Model projects with customers, including LLM API integration, current knowledge of foundation models, prompt engineering, RAG, fine tuning, and managing AI projects.
  • You either come from an Engineering background, or your desire to ship working solutions has allowed you to build out a range of technical solutions.
  • University degree in computer science, engineering, mathematics or related fields.
  • Solutioning: ability to develop and articulate an AI solution vision to technical and business stakeholders with customers and partners to match value proposition to business needs.
  • Thrived in another fast-paced SaaS startup or scale-up during a high-growth phase.
Responsibilities
  • Develop and present proposals to Leadership, Product and Engineering.
  • Champion key new capabilities to productionize and scale the most ambitious applications of GenAI.
  • Stay involved throughout the implementation of features scheduled into the roadmap.
Desired Qualifications
  • Thrived in another fast-paced SaaS startup or scale-up during a high-growth phase.

V7 Labs specializes in automated image annotation and AI training, primarily serving clients in the medical and scientific sectors. Their main product, V7 Darwin, allows users to label imperfections in images and create segmentation masks, which are essential for training neural networks. This platform significantly speeds up the process of generating high-quality annotated datasets, making it ten times more efficient. V7 Labs differentiates itself from competitors by focusing on the specific needs of healthcare providers and research institutions, ensuring that their tools meet the rigorous standards required for FDA compliance. The company's goal is to enhance the accuracy and efficiency of object detection and documentation in various industries through their subscription-based software as a service (SaaS) model.

Company Size

51-200

Company Stage

Series A

Total Funding

$48.6M

Headquarters

London, United Kingdom

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with Mauna Kea enhances AI applications in medical imaging.
  • V7 Go positions V7 Labs to streamline legal due diligence processes.
  • $3M funding boosts development of automated training data workflows.

What critics are saying

  • Competition from companies like OpenAI may challenge V7 Labs' market position.
  • Diminishing high-quality training data supply could impact AI model quality.
  • Reliance on partnerships may pose risks if outcomes are not as expected.

What makes V7 Labs unique

  • V7 Labs specializes in automated image annotation for medical and scientific fields.
  • V7 Darwin platform scales segmentation mask creation by 10x, enhancing efficiency.
  • V7 Go tool automates legal data extraction, expanding into the legal sector.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Private Healthcare via Bupa

Private Healthcare via Vitality

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Company Equity

Performance Bonus

Enhanced Parental Leave

Learning and Development Budget

Wellness Program

Mental Health Support

Gym Membership

Home Office Stipend

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-9%

2 year growth

4%
Decrypt
Nov 12th, 2024
Openai'S Next-Gen Model Hits Performance Wall: Report

Decrypt’s Art, Fashion, and Entertainment Hub. Discover SCENEOpenAI's upcoming artificial intelligence model is delivering smaller performance gains than its predecessors, sources familiar with the matter told The Information.Employee testing reveals Orion achieved GPT-4 level performance after completing only 20% of its training, The Information reports.The quality increase from GPT-4 to the current version of GPT-5 seems to be smaller than that of GPT-3 to GPT-4.“Some researchers at the company believe Orion isn’t reliably better than its predecessor in handling certain tasks, according to the (OpenAI) employees,” The Information reported. “Orion performs better at language tasks but may not outperform previous models at tasks such as coding, according to an OpenAI employee.”While Orion getting closer to GPT-4 at 20% of its training might sound impressive to some, it is important to note that the early stages of AI training typically deliver the most dramatic improvements, with subsequent phases yielding smaller gains.So, the remaining 80% of training time isn’t likely to produce the same magnitude of advancement seen in previous generational leaps, sources said.The limitations emerge at a critical juncture for OpenAI following its recent $6.6 billion funding round.The company now faces heightened expectations from investors while grappling with technical constraints that challenge traditional scaling approaches in AI development. If these early versions don't meet expectations, the company’s upcoming fundraising efforts may not be met with the same hype as before—and that could be a problem for a potentially for-profit company, which is what Sam Altman seems to want for OpenAI.Underwhelming results point to a fundamental challenge facing the entire AI industry: the diminishing supply of high-quality training data and the need to remain relevant in a field as competitive as generative AI.Research published in June predicted that AI companies will exhaust available public human-generated text data between 2026 and 2032, marking a critical inflection point for traditional development approaches."Our findings indicate that current LLM development trends cannot be sustained through conventional data scaling alone," the research paper states, highlighting the need for alternative approaches to model improvement, including synthetic data generation, transfer learning from data-rich domains, and the use of non-public data.The historical strategy of training language models on publicly available text from websites, books, and other sources has reached a point of diminishing returns, with developers having "largely squeezed as much out of that type of data as they can," according to The Information.How OpenAI is Tackling This Issue: Reasoning vs. Language ModelsTo tackle these challenges, OpenAI is fundamentally restructuring its approach to AI development.“In response to the recent challenge to training-based scaling laws posed by slowing GPT improvements, the industry appears to be shifting its effort to improving models after their initial training, potentially yielding a different type of scaling law,” The Information reports.To achieve this state of continuous improvement, OpenAI is separating model development into two distinct tracks:The O-Series (which seems to be codename Strawberry), focused on reasoning capabilities, represents a new direction in model architecture. These models operate with significantly higher computational intensity and are explicitly designed for complex problem-solving tasks.The computational demands are substantial, with early estimates suggesting operational costs at six times that of current models

Artificial Lawyer
Nov 5th, 2024
Product Walk Through: V7 Go – Genai Legal Data Extraction

This week’s Product Walk Through is with V7 Labs and its genAI-driven Go capability for extracting key data from legal documents.V7 Labs is an AI development group and Go is its tool specifically designed for automating tasks in knowledge work, in this case legal data extraction from collections of deal documents to produce a due diligence report.Showing how it works are Will Mangion, Sales Lead, and Patrick Frenett, Solutions Engineer, at V7. The demo runs to about 15 mins, followed by 7 mins of QA with Artificial Lawyer on what the product can do. Please press Play to watch / listen to the video inside the page. VIDEO. AL TV Productions, 2024.The company added that: ‘V7 Go allows legal teams to build Generative AI workflows that emulate human work. With natural language-based instructions users can build flexible data extraction pipelines in minutes – enabling impactful automation processes to be created by anyone with an idea and a laptop.’You can find more information about V7 Go here.—Note: you can customise the video playback and add automated captions by using the icons.[ This is a sponsored AL TV Product Walk Through with V7 Labs

Artificial Lawyer
Aug 5th, 2024
Pinsent Masons Deploys ‘V7 Go’ Genai Platform

International law firm Pinsent Masons is to deploy a new genAI automation platform, ‘V7 Go’, created by London-based V7 Labs, which provides AI products and services to clients across multiple sectors, including Sony and Roche.So, what is V7 Go? Well, the short answer is that it’s a highly structured genAI wrapper that helps users to apply, for example, an LLM’s abilities to handle text queries in a more focused way as part of a customised workflow that uses multiple prompts. It operates with OpenAI, Anthropic and Gemini models.Orlando Conetta, Head of Research and Development at Pinsent Masons, put it this way: ‘V7 Go is the equivalent of Excel for natural language processing, enabling users to scale complex chains of prompts across large volumes of documents. All through an intuitive and powerful UI.’Or, as the company explained: ‘Go is more accurate and robust than calling a model provider directly. By breaking down complex tasks into reasoning steps with Index Knowledge, Go enables LLMs to query your data more accurately than an out of the box API call. Combining this with conditional logic, which can route high sensitivity data to a human review, Go builds robustness into your AI powered workflows.’And perhaps another way of putting it would be to say that although an LLM on its own can do a lot for you, an intermediary layer between the genAI capabilities and your range of legal texts that has chained prompts and rules-based logic steps should help to shape those outputs into exactly the end results you want.Areas where V7 Labs helps. V7 Go is in addition to this.‘V7 Go’s capabilities offer immediate opportunities for increasing efficiency, scale, and quality at Pinsent Masons

Business Wire
Mar 27th, 2024
Mauna Kea Technologies Partners With V7 To Develop Innovative Ai Applications With Cellvizio

PARIS BOSTON LONDON--(BUSINESS WIRE)--Regulatory News:. Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, and V7, a leading AI and data labeling company, today announced their partnership to develop a cutting-edge infrastructure for AI applications with Cellvizio. Mauna Kea and V7 will collaborate to establish a strategic data repository of clinically-augmented, curated and annotated Cellvizio® images. This foundational data asset will spearhead Mauna Kea’s forthcoming AI-driven innovations, including:

Business Wire
Mar 27th, 2024
Mauna Kea Technologies S’Associe À V7 Pour Le Développement D’Applications Innovantes D’Ia Avec Le Cellvizio

PARIS BOSTON LONDRES--(BUSINESS WIRE)--Regulatory News:. Mauna Kea Technologies (Euronext Growth : ALMKT) inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), et V7, société leader en matière d'intelligence artificielle (IA) et de labélisation des données, ont annoncé aujourd'hui leur partenariat en vue de développer une infrastructure de pointe pour des applications d’IA avec le Cellvizio. Mauna Kea et V7 collaboreront pour créer un registre de données stratégiques constitué d'images Cellvizio® associées à des données cliniques, traitées et annotées. Cette base de données sera le fer de lance des prochaines innovations de Mauna Kea axées sur l'IA avec :